Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Alberto Ortíz(Universidad Autónoma de Madrid), Adrian Covic(Grigore T. Popa University of Medicine and Pharmacy), Danilo Fliser(Saarland University), Denis Fouque(Centre Nantais de Sociologie), David Goldsmith(St Thomas' Hospital), Mehmet Kanbay(Istanbul Medeniyet University), Francesca Mallamaci(Istituto di Fisiologia Clinica), Ziad A. Massy(Université de Versailles Saint-Quentin-en-Yvelines), Patrick Rossignol(Université de Lorraine), R. Vanholder(Ghent University Hospital), Andrzej Więcek(Medical University of Silesia), Carmine Zoccali(Istituto di Fisiologia Clinica), Gérard M. London(Hôpital Européen Georges-Pompidou)
Cited by 432
Abstract
Related Papers
Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy
Gennaro Cice, Luigi Ferrara, Antonello D’Andrea et al.|Journal of the American College of Cardiology|2003|534